LNA Santé SA (ENXTPA:LNA) agreed to acquire Clinique Développement SAS from its partners on October 9, 2020. Clinique Développement reported consolidated turnover of €76.6 million in 2019. The transaction is subject to review by the Competition Authority. The transaction was approved by the Competition Authority on October 28, 2020. The transaction is expected to complete in November 2020. Fabrice Scheer, Franck Noat, Nicolas Senlis, Lahlou Khelifi, Leo Fallourd and Florian Dumas of Corporate Finance Alantra acted as financial advisors for LNA Santé SA. Delphine Bariani, Marie Gabiano, Pierre Bouley, Annaelle Lousquy and Etienne Pujol of Berrylaw acted as legal and tax due diligence advisors while Philippe Serzec and Benoît Cambournac of PwC acted as financial due diligence advisors to LNA Santé. Gilles Toussaint, Caroline Houry and Maud Van de Louw of La Baume Finance acted as financial advisors to shareholders of Clinique Développement. Vincent Siguier, Réginald Legenre, Astrid Chauwin and Guillaume Roland of Herald Avocats acted as legal advisors to Clinique Développement. Vania Mermoud and Armel Pédron of Deloitte Finance carried out Vendor Due Diligence.

LNA Santé SA (ENXTPA:LNA) completed the acquisition of Clinique Développement SAS from its partners on December 1, 2020. The 900 employees of the Clinique Développement group as well as all the prívate practitioners will join LNA Santé SA.